Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Cerlapirdine

Generic Name: Cerlapirdine

Drug Type: Small Molecule

Chemical Formula: C_₂₂H_₂₃N_₃O_₃S

CAS Number: 925448-93-7

Unique Ingredient Identifier: EK40PJ0V49

Overview

Cerlapirdine has been investigated for the treatment of Alzheimer Disease.

Background

Cerlapirdine has been investigated for the treatment of Alzheimer Disease.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding In Brain Using PET (Positron Emission Tomography) In Healthy Volunteers

Phase 1

Completed

Posted: 2010/12/03

Sponsor:Pfizer

ID:NCT01253655

Study Evaluating How Quickly And To What Extent The 14-Carbon-SAM-531 Is Absorbed/Converted/Eliminated In Male Subjects

Phase 1

Completed

Posted: 2009/05/21

Sponsor:

Wyeth is now a wholl...

ID:NCT00906191

Study Evaluating The Potential Interaction Between Verapamil Immediate Release And SAM-531 When Co-Administered

Phase 1

Completed

Posted: 2008/09/03

Sponsor:

Wyeth is now a wholl...

ID:NCT00745576

Study Evaluating Safety, Tolerability and Pharmacokinetics of Single and Multiple Dose of SAM-531

Phase 1

Completed

Posted: 2008/07/31

Sponsor:

Wyeth is now a wholl...

ID:NCT00726115

Study Evaluating Effects of SAM-531 on Sleep Electroencephalogram (EEG) and Quantitative Wake EEG in Healthy Subjects

Phase 1

Completed

Posted: 2007/08/22

Sponsor:

Wyeth is now a wholl...

ID:NCT00519298

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy